David G. DeNardo
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Google:
"David DeNardo"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lander VE, DeNardo DG. (2023) Pancreatic Cancer's PD1-roadblock: When T-cell reinvigoration is not enough. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Storrs EP, Chati P, Usmani A, et al. (2023) High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival. Npj Precision Oncology. 7: 105 |
| Baer JM, Zuo C, Kang LI, et al. (2023) Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC. Nature Immunology |
| Herzog BH, Baer JM, Borcherding N, et al. (2023) Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer. Science Translational Medicine. 15: eadh8005 |
| Liu X, Hogg GD, Zuo C, et al. (2023) Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity. Cancer Cell |
| James CA, Baer JM, Zuo C, et al. (2023) Systemic Alterations in Type-2 Conventional Dendritic Cells Leads to Impaired Tumor Immunity in Pancreatic Cancer. Cancer Immunology Research |
| Panni UY, Chen MY, Zhang F, et al. (2023) Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology. Cancer Immunology, Immunotherapy : Cii |
| Selli ME, Landmann J, Terekhova M, et al. (2023) Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction. Blood |
| Zuo C, Baer JM, Knolhoff BL, et al. (2023) Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. The Journal of Experimental Medicine. 220 |
| Faget DV, Luo X, Inkman MJ, et al. (2023) p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy. Cancer Discovery |